NO811721L - R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape - Google Patents

R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape

Info

Publication number
NO811721L
NO811721L NO811721A NO811721A NO811721L NO 811721 L NO811721 L NO 811721L NO 811721 A NO811721 A NO 811721A NO 811721 A NO811721 A NO 811721A NO 811721 L NO811721 L NO 811721L
Authority
NO
Norway
Prior art keywords
coating
pharmaceutical preparation
release property
improved release
active substance
Prior art date
Application number
NO811721A
Other languages
English (en)
Norwegian (no)
Inventor
Conny Boerje
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20341009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO811721(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NO811721L publication Critical patent/NO811721L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO811721A 1980-05-21 1981-05-20 R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape NO811721L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8003805A SE8003805L (sv) 1980-05-21 1980-05-21 En farmaceutisk beredning med forbettrade utlosningsegenskap

Publications (1)

Publication Number Publication Date
NO811721L true NO811721L (no) 1981-11-23

Family

ID=20341009

Family Applications (1)

Application Number Title Priority Date Filing Date
NO811721A NO811721L (no) 1980-05-21 1981-05-20 R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape

Country Status (9)

Country Link
EP (1) EP0040590A3 (fr)
DK (1) DK221281A (fr)
ES (1) ES8301630A1 (fr)
GR (1) GR75634B (fr)
NO (1) NO811721L (fr)
PH (1) PH16539A (fr)
PT (1) PT73065B (fr)
SE (1) SE8003805L (fr)
ZA (1) ZA813017B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
JPS57500432A (fr) * 1980-03-20 1982-03-11
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3151196A1 (de) * 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat
US5472710A (en) * 1988-04-16 1995-12-05 Schwarz Pharma Ag Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
ES2077023T3 (es) * 1989-03-10 1995-11-16 Yamanouchi Pharma Co Ltd Material de recubrimiento que controla la liberacion de un medicamento para formulaciones de actividad prolongada.
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
GB9015822D0 (en) * 1990-07-18 1990-09-05 Beecham Group Plc Compositions
GEP19971086B (en) * 1991-02-22 1997-12-02 Tillotts Pharma Ag Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
AU1587392A (en) * 1991-03-15 1992-10-21 Norwich Eaton Pharmaceuticals, Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE29502547U1 (de) * 1995-02-16 1995-03-30 Röhm GmbH, 64293 Darmstadt Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
CA2320193A1 (fr) 1998-02-10 1999-08-19 Welfide Corporation Preparations a liberation controlee
DE59905248D1 (de) 1999-01-29 2003-05-28 Disphar Int Bv Pharmazeutische zusammensetzungen
IT1318376B1 (it) * 2000-03-07 2003-08-25 Pharmatec Internat S R L Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.
CA2359812C (fr) 2000-11-20 2004-02-10 The Procter & Gamble Company Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
AU2003269741A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited Coated sustained release tablets of a hygroscopic compound for once-a-day therapy
AR040682A1 (es) 2002-07-25 2005-04-13 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
EP1732524B1 (fr) 2004-03-30 2012-08-22 Relypsa, Inc. Procedes et compositions pour le traitement de desequilibres ioniques
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
CN101849920A (zh) * 2004-08-13 2010-10-06 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途
US8889184B2 (en) * 2006-09-07 2014-11-18 Losan Pharma Gmbh Particulate form of a pharmaceutical composition which is easy to swallow
ES2715274T3 (es) 2008-01-10 2019-06-03 Evonik Roehm Gmbh Preparación farmacéutica o nutracéutica recubierta con liberación de sustancias activas mejorada
CN101888832A (zh) * 2008-01-10 2010-11-17 赢创罗姆有限公司 加快的活性物质受控释放的包衣药物或包衣营养制剂
AU2009298139B2 (en) 2008-10-03 2015-02-19 Dr. Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
CA3018328A1 (fr) 2014-10-31 2016-04-30 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
FR3102931B1 (fr) 2019-11-13 2021-12-24 Ethypharm Sa Procédé de fabrication d’une composition pharmaceutique à administration orale et à délivrance colonique
EP4057998A1 (fr) 2019-11-13 2022-09-21 Ethypharm Procédé de fabrication d'une composition pharmaceutique à administration orale et à délivrance colonique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
GB1297719A (fr) * 1970-06-11 1972-11-29
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung

Also Published As

Publication number Publication date
SE8003805L (sv) 1981-11-22
DK221281A (da) 1981-11-22
ZA813017B (en) 1982-05-26
PH16539A (en) 1983-11-10
EP0040590A3 (fr) 1983-01-12
ES502345A0 (es) 1982-12-16
ES8301630A1 (es) 1982-12-16
PT73065B (en) 1983-02-08
EP0040590A2 (fr) 1981-11-25
PT73065A (en) 1981-06-01
GR75634B (fr) 1984-08-01

Similar Documents

Publication Publication Date Title
NO811721L (no) R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape
DE69622510D1 (de) Nifedipinzubereitung mit langanhaltender Freisetzung
DE3855852D1 (de) Kugelförmige Granula mit Kern sowie deren Herstellung
NO161124C (no) Polymerpulver for aa danne et enterisk belegg paa farmasoeytiske doseringsformer, og fremgangsmaate for fremstilling derav.
DK400685D0 (da) Praeparat med kontrolleret afgivelse
ES2001897A6 (es) Procedimiento para la fabricacion de una tableta de liberacion controlada
TR199800121T1 (xx) Uzat�lm�� etki s�resine sahip ipratropyumbromid'in bir enantiyomeri.
ATE286724T1 (de) Überzogene arzneiformen mit kontrollierter wirkstoffabgabe
BE889698A (fr) Derives d'hydantoine, leur procede de preparation et leur application therapeutique
OA07628A (fr) Résinate d'un acide carboxylique substitué, procédés pour sa préparation, son utilisation et compositions pharmaceutiques le contenant.
ES485540A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas, congrupos ester funcionalizados
KR860000865A (ko) 약제 제형의 제조방법
PT71495A (fr) Procede d'obtention d'extraits de lierre grimpant et de compositions pharmaceutiques qui en contiennent
FR2453648A1 (fr) Nouvelles compositions pharmaceutiques a base d'une quinazolinone exercant une action analgesique et d'un agent myotonolytique
BE883943A (fr) Derives de l'enkaphaline, leur preparation et leurs utilisations therapeutiques, notamment comme analgesiques
PT72397B (en) Process for the preparation of n,n-dialkyl-o-(pyrazol-5-yl) carbanic acid derivatives and insecticide and nematicide compositions thereof
JPS649205A (en) Fixer composition, organic polymer for fixer, coating supporter and manufacture
ES8600282A1 (es) Procedimiento para la obtencion de 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro)1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol
NZ189212A (en) 3-amino substituted 1,5-cyclohexadiene carboxylic acid derivatives and pharmaceutical compositions
JPS5748908A (en) Prolonged release type nicomol pharmaceutical
JPS6422824A (en) Antifungal agent
ES457496A1 (es) Procedimiento para la obtencion de una composicion pulveru- lenta e hidrosoluble de sulfamidina y pirimetamina.
JPS5231119A (en) Imitated animal hairlike synthetic fibers
JPS5770861A (en) N,n'-bis(5-oxo-1-methyl-pyrrolidine-2-yl-acetic acid)-hydrazide, manufacture and medicinal composition
FR2569690B1 (fr) Sel de d,l-lysine de l'acide 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole-3-acetique, son procede de preparation et compositions pharmaceutiques le contenant